Clinical Trial Update: Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea [Phase 3]

View source ↗

Summary

Phase 3 study evaluating prulifloxacin vs placebo for traveler's diarrhea has completed, reporting on safety and efficacy in adult travelers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis
• Traveler Diarrhea

Drugs mentioned

• Prulifloxacin (Prulifloxacin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Acute Gastroenteritis in Adult Travelers | Phase 3 | Status: COMPLETED